BIRMINGHAM, Ala., Feb. 21, 2018 /PRNewswire/ -- The innovative late development-stage pharmaceutical startup, Bridge Therapeutics®, has named David H. Bergstrom, Ph.D. as its new Chief Operating ...
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
Dr. Sune Karl Bergstrom, the Nobel laureate who was the first to isolate and identify a family of natural chemicals involved in such disparate functions as birth, blood clotting and pain control, died ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics, a biopharmaceutical company developing its Fleximer® antibody-drug conjugate (ADC) platform and therapeutics, today announced two executive ...
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of David H. Bergstrom Ph.D. to the position of Senior Vice President of Pharmaceutical Development. Dr.
Ophthalmologist Lance Bergstrom ’86 of Fargo, N.D., chose his field in part because eye surgeries have a huge impact on a patient’s quality of life. “I also was cognizant of the fact that it’s a great ...
Dr. Amy Bergstrom is a life-long educator and is Chief Diversity Officer... Dr. Amy Bergstrom is a life-long educator and is Chief Diversity Officer at the College of St. Scholastica. She is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback